Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Featured study
Tobacco Product Advertising Study

Tobacco Product Advertising Study

21 years - 29 years
Accepts healthy volunteer
All genders
The University of Pennsylvania's Tobacco Use Research Center is recruiting young adults between the ages of 21-29 who use or have previously used cigarettes and other tobacco products for a research study evaluating reactions to tobacco product advertising. This is not a quit smoking study.
Learn More
Featured study

A Multicenter, Double-Blind, Randomized, Parallel-Group, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy and an Open-labeled Long-term Safety Extension Treatment

18 years - 74 years
All genders
Phase 3
Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Seltorexant 20 mg as Adjunctive Therapy to Antidepressants in Adult and Elderly Patients with Major Depressive Disorder with Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy and an Open-labeled Long-term Safety Extension Treatment with Seltorexant
Learn More
Featured study
Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression

Clinical Study to Evaluate the Efficacy and Safety of MK-1942 Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression

18 years - 65 years
Male
Phase 2
Normal 0 false false false EN-US X-NONE AR-SA This research study invites participants that are taking an antidepressant that has not fully helped with their depression. MK-1942 is the investigational product under study in this research trial, the participant will be taking along with their current antidepressant to test its …
Learn More
Featured study
The Gen-Y Study: Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer

The Gen-Y Study: Randomized trial of universal vs. guideline-directed germline testing among young adults with cancer

18 years - 40 years
All genders
Our study aims to determine whether genetic testing should be recommended for young adults with cancer. This type of testing can show if your cancer may be caused by inherited risk.  This information can help guide effective screening and treatment for cancer in young adults and their families. This is …
Check Eligibility
Featured study
Prospective evaluation of the durability of aortic bioprostheses/valves with RESILIA tissue (RESILIENCE Trial)

Prospective evaluation of the durability of aortic bioprostheses/valves with RESILIA tissue (RESILIENCE Trial)

18 years - 65 years
All genders
The objective of this observational trial is to determine time to valve failure due to valve deterioration requiring re-intervention and collect/investigate early potential predictors of valve durability (e.g., calcification and hemodynamic deterioration) in RESILIA tissue valves.
Learn More
Featured study
PROTECT- study of the efficacy and safety of sparsentan for the treatment of Immunoglobulin A (IgAN) nephropathy

PROTECT- study of the efficacy and safety of sparsentan for the treatment of Immunoglobulin A (IgAN) nephropathy

18 years - 99 years
All genders
Phase 3
Immunoglobulin A nephropathy (IgAN) is a rare disease that affects the kidneys, mostly in teens and adults. Kidneys are important to your health because they filter waste materials such as salts, toxins and water out of the blood. The waste is passed out of your body as urine (pee). IgAN …
Learn More
Featured study

The Proactive Celiac Study

18 years - 69 years
All genders
Phase 2
Are you still experiencing celiac disease symptoms despite your best efforts to follow a gluten-free diet?The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused …
Learn More
Featured study

A phase 3 multicenter randomized double-blind placebo-controlled study to assess the efficacy and safety of 400 mg twice a day oral ladarixin in patients with new-onset type 1 diabetes and a low residual -cell function

99 years or below
All genders
The objective of this clinical trial is to assess whether ladarixin treatment is effective in preserving -cell function and delaying the progression of T1D in adolescent and adult patients. The safety of ladarixin in the specific clinical setting will be also evaluated.
Learn More
Featured study
ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

ALTUS: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

18 years - 99 years
All genders
Observational
For subjects age 18 years and older who are at an increased risk for HCC and for whom HCC surveillance is appropriate, including subjects with cirrhosis or non-cirrhotic subjects with Hepatitis B. Approximately 3,000 subjects are expected to be enrolled, comprised of approximately 2,222 ultrasound surveillance subjects and 778 subjects …
Learn More
Featured study
Research Study on Whether a Combination of 2 Medicines Works in People With Non-alcoholic Steatohepatitis (NASH)

Research Study on Whether a Combination of 2 Medicines Works in People With Non-alcoholic Steatohepatitis (NASH)

18 years - 99 years
All genders
This study investigates the effects of a combination of two investigational medications on non-alcoholic steatohepatitis (NASH).The study evaluates whether combining these medications can reduce liver damage associated with NASH.Who can participate: Adults aged 18 and older with histological evidence of NASH can participate.Study details: Participants will take part in a …
Learn More
51 - 60 of 1243